PaulSorajjaMD

Interventional Cardiology

Roger L. and Lynn C. Headrick Family Chair, Valve Science Center; Director, Center for Valve and Structural Heart Disease Minneapolis Heart Institute Abbott Northwestern Hospital

Join to view full profile

Dr. Sorajja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sorajja's full profile

Already have an account?

Office
800 E 28th St
Ste H2100
Minneapolis, MN 55407
Phone+1 612-775-3030

Fax+1 612-863-1681
Is this information wrong?

Summary

Dr. Paul Sorajja is a cardiologist in Minneapolis, MN and is affiliated with Abbott Northwestern Hospital. He received his medical degree from Mayo Clinic School of Medicine and has been in practice 20 years. He specializes in interventional cardiology, hypertrophic cardiomyopathy, structural heart therapy, and valvular heart disease.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2004 - 2006
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2001 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2000 - 2001
Mayo Clinic College of MedicineClass of 1997

Certifications & Licensure

MN State Medical License 1998 - 2025
FL State Medical License 2010 - 2015
AZ State Medical License 2012 - 2014
LA State Medical License 2014 - 2014
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACC) American College of Cardiology

Clinical Trials

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable
Portico NG Approval Study Start of enrollment: 2019 Sep 17
Active, not recruiting
Not Applicable
MitraClip REPAIR MR Study Start of enrollment: 2020 Jul 21
Recruiting
Not Applicable
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2019 Jun 10
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System Start of enrollment: 2020 Jul 14
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

181 citations
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Ass...
Rick A Nishimura, Catherine M Otto, Robert O Bonow, Blase A Carabello, John P Erwin 3rd
Circulation. 2014-06-10
11 citations
Incidence and Standardized Definitions of Mitral Valve Leaflet Adverse Events After Transcatheter Mitral Valve Repair: the EXPAND Study.
Federico M. Asch, Stephen H. Little, G. Burkhard Mackensen, Paul A. Grayburn, Paul Sorajja
Eurointervention. 2021-05-25
253 citations
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Asso...
Steve R Ommen, Seema Mital, Michael A Burke, Sharlene M Day, Anita Deswal
Journal of the American College of Cardiology. 2020-12-22

Journal Articles

Atrial Shunting for Heart Failure
Peter M Eckman, Paul Sorajja, Michael A Samara, ScienceDirect
Original Investigation Editorial Comment Searching for Surgical Alternatives in Hypertrophic Cardiomyopathy∗
William T Katsiyiannis, Paul Sorajja, Kevin M Harris, ScienceDirect
Prevalence, Trends, and Outcomes of Higher Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes☆☆☆
Ivan Chavez, M Nicholas Burke, Daniel Lips, Jay Traverse, Emmanouil S Brilakis, Anil Poulose, Michael Mooney, Paul Sorajja, Yale Wang, ScienceDirect
Meta‐Analysis of the Impact of Successful Chronic Total Occlusion Percutaneous Coronary Intervention on Left Ventricular Systolic Function and Reverse Remodeling
Ivan Chavez, Yale Wang, Emmanouil S Brilakis, Louis P Kohl, Daniel Lips, Michael Mooney, Paul Sorajja, Anil Poulose, M Nicholas Burke, Jay Traverse, Journal of Interventional Cardiology
Join now to see all

Lectures

Once TMVR Is Refined, It Will Be the Preferred Therapy for Most MR Patients
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019

Other

Searching for Surgical Alternatives in Hypertrophic Cardiomyopathy
Paul Sorajja, MD, JACC: Cardiovascular Imaging
https://www.doximity.com/articles/7753abf6-8311-4177-8f60-04b04b5d00d8
UpToDate, Wolters Kluwer Health - 2013-03-18

Authored Content

Hemodynamic Profiles and Clinical Response to Transcatheter Mitral RepairAugust 2022
Searching for Surgical Alternatives in Hypertrophic CardiomyopathyOctober 2018
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
Early Experience with New Transcatheter Mitral Valve ReplacementJanuary 2018
Early Experience with New Transcatheter Mitral Valve ReplacementJanuary 2018
Join now to see all

Press Mentions

Top Doctors 2023: Breaking BarriersJuly 27th, 2023
Cover Story | ACC.23/WCC: Uniting the Global Cardiovascular CommunityMarch 31st, 2023
Transcatheter Repair for Patients with Tricuspid RegurgitationMarch 9th, 2023
Join now to see all